New Advanced Energy Surgical Device Designed To Speed Recovery Of Patients Undergoing Orthopedic Procedures

Main Category: Bones / Orthopaedics
Article Date: 21 Sep 2008 - 0:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

As part of its ongoing effort to improve patient outcomes for orthopedic procedures and reduce non-routine discharges for its hospital customers, Salient Surgical Technologies, Inc. (the Company) introduced the Aquamantys™ Malleable Bipolar Sealer with Light (MBS).

The MBS employs Transcollation™ technology to significantly reduce bleeding in hard-to-reach anatomy during joint replacement surgery. Reducing blood loss improves visualization for the surgeon, can result in improved clinical outcomes for the patient and may result in lower costs to the hospital.

The innovation of the MBS is a malleable shaft that allows surgeons to shape the device to help fit the particular surgical situation. The shaft also features a lighted tip to improve visibility. The MBS is used with the same Aquamantys System Generator as the Company's standard 2.3 and 6.0 Bipolar Sealer devices.

"Our research and development group worked closely with our surgeon partners to design the MBS for tight surgical situations. We are delighted to offer this expansion of our product line, and hope it will be well received by both new and existing customers," said Joe Army, CEO of Salient Surgical Technologies. "The MBS represents the first in a series of new product offerings we have planned for the near future."

Salient Surgical Technologies, Inc. is a medical technology company that develops and markets innovative tools designed to improve patient outcomes and reduce the cost of medical care. The Company's proprietary Transcollation™ technology is designed to deliver economic value to hospitals and simplify surgery by providing surgeons the ability to significantly reduce blood loss in a broad range of procedures. Salient's Aquamantys™ System uses Transcollation™ technology to help surgeons improve patient outcomes for orthopedic reconstruction, spinal fusion and solid organ resection procedures. To date, Transcollation™ technology has been used in over 200,000 surgical procedures.

Salient Surgical Technologies, Inc.